Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

The Next Test for AI in Pharmacovigilance Is Trust, Not Accuracy
An AI model can be right and still not be trusted. That’s what Bristol Myers Squibb (BMS) found six months into rolling out AI-powered adverse event processing: while F1 performance scores were tracking upward, the audit trail found reviewers still reopening cases the system had already cleared. read more
An Interview With Dave Miller, Ph.D.
Early formulation decisions can make or break a program, yet they’re often made under significant data constraints. What are the most common mistakes sponsors make when they rush that decision, and what does it typically cost them downstream? read more
The Tough Decisions
While there are many drugs to make the end of life easier and less painful, the fundamental problem of deciding when to end life is a topic and a decision few want to address. read more
Representative Environmental Monitoring: Why Monitoring Activities Are Not Interchangeable Within a Contamination Control Strategy
Environmental monitoring activities should not be assumed to be interchangeable because contamination control questions are not interchangeable. Different contamination control questions require different information. Environmental monitoring exists to generate that information. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

MedPharm Signs First-to-File Generic Topical Supply Deal
Tuesday, November 10, 2026
MedPharm has added a first-to-file generic topical product to its commercial manufacturing portfolio. Under the agreement, MedPharm will serve as the ... read more
Evonik Produces First Lipids at New Indiana Center
Tuesday, November 10, 2026
Evonik has manufactured the first batch of GMP-quality pharmaceutical lipids at its new Lipid Innovation Center in Lafayette, Indiana. The large-scale... read more
NAMSA, Advanced Medical Solutions Form Partnership
Tuesday, November 10, 2026
NAMSA and Advanced Medical Solutions (AMS) have entered into a preferred partnership to accelerate the development and commercialization of AMS's ... read more
Simtra Opens $250M+ Bloomington Expansion
Tuesday, November 10, 2026
Simtra BioPharma Solutions has opened Building H, a more than $250 million expansion of its Bloomington, Indiana manufacturing campus. The CDMO, ... read more
PharmaLogic to Acquire Lantheus CDMO Business
Tuesday, November 10, 2026
PharmaLogic Holdings has signed a definitive agreement to acquire the CDMO business and Springfield, New Jersey manufacturing facility from Lantheus ... read more